Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
<h4>Aims</h4> <p>To investigate if recent technical and procedural developments in percutaneous coronary intervention (PCI) significantly influence outcomes in appropriately selected patients with three-vessel (3VD) coronary artery disease.</p> <h4>Methods and Results&...
المؤلفون الرئيسيون: | Escaned, J, Collet, C, Ryan, N, De Maria, G, Walsh, S, Sabate, M, Davies, J, Lesiak, M, Moreno, R, Cruz-Gonzalez, I, Hoole, S, Ej West, N, Piek, J, Zaman, A, Fath-Ordoubadi, F, Stables, R, Appleby, C, van Mieghem, N, van Geuns, R, Uren, N, Zueco, J, Buszman, P, Iñiguez, A, Goicolea, J, Hildick-Smith, D, Ochala, A, Dudek, D, Hanratty, C, Cavalcante, R, Kappetein, A, Taggart, D, van Es, G, Morel, M, de Vries, T, Onuma, Y, Farooq, V, Serruys, P, Banning, A |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Oxford University Press
2017
|
مواد مشابهة
-
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study
حسب: Banning, AP, وآخرون
منشور في: (2021) -
Contemporary outcomes following coronary artery bypass graft surgery for left main disease
حسب: Modolo, R, وآخرون
منشور في: (2019) -
Improvements in thermoforming simulation by use of 3D digital image correlation
حسب: B. Van Mieghem, وآخرون
منشور في: (2015-02-01) -
Pharmaco-invasive therapy: Early implementation of statins and proprotein convertase subtilisin/kexin type 9 inhibitors after acute coronary syndrome
حسب: F. B. Mensink, وآخرون
منشور في: (2022-12-01) -
Doctor on a mountaineering expedition.
حسب: A'Court, C, وآخرون
منشور في: (1995)